Outpatient management of chronic heart failure.

about

Pharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemia.

P2860

Q30250020-1A8E9887-C5B4-47E5-B344-79CD081563D1

P2860

Outpatient management of chronic heart failure.

Item

http://www.wikidata.org/entity/Q50998627

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Outpatient management of chronic heart failure.

@en

Outpatient management of chronic heart failure.

@nl

type

Item

label

Outpatient management of chronic heart failure.

@en

Outpatient management of chronic heart failure.

@nl

prefLabel

Outpatient management of chronic heart failure.

@en

Outpatient management of chronic heart failure.

@nl

P1476

Outpatient management of chronic heart failure

@en

P2093

Elisabeth Kaldara

http://www.w3.org/2001/XMLSchema#string

John N Nanas

http://www.w3.org/2001/XMLSchema#string

Stamatis Adamopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Cochrane Database of Systematic Reviews

Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

Antithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implications

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study

A comparison of the aldosterone-blocking agents eplerenone and spironolactone

Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

P304

17-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2015.978286

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Despina Sanoudou

P577

2014-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25480690

http://www.w3.org/2001/XMLSchema#string

Outpatient management of chronic heart failure.

about

P2860

P2860

Outpatient management of chronic heart failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698